To study the effect of amrutadi churn in the management of amavata

Randomized controlled clinical trial of Amrutadi churna in the management of Amavata with special reference to Rheumatoid Arthritis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037759

Enrollment

Registered

2021-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age-18 to 60 yrs 2.Irrespective of gender and socio-economic status 3.Patients with signs and symptoms of Amavata will be included in the study 4.chronicityof <5yrs

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.patients with cardiac disease,HIV,malignancy and major illness

Design outcomes

Primary

Measure	Time frame
Amrutadi churna is effective in the management of AmavataTimepoint: 60 days	—

Secondary

Measure	Time frame
Panchasama chruna is more effective in management of AmavataTimepoint: 60 days	—

Countries

India

Contacts

Public ContactHema Gajanan Mphite

Hon.Shri Annasaheb Dange ayurved medical college and PG research center, Ashta Tal-Walwa Dist-sangli

drvarshaskhot@gmail.com9423565886

Outcome results